查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1605808

医药品·医疗设备组合产品市场，规模，占有率，趋势，产业分析报告:各产品类型，各用途，各终端用户，各地区 - 市场预测，2025年～2034年

Drug Device Combination Products Market Size, Share, Trends, Industry Analysis Report, By Type, Application, End user, and Region- Market Forecast, 2025 - 2034
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2034年，全球组合药物和医疗器材市场预计将达到3,435.9亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

世界各地不断增长的老年人口正在推动全球药物/医疗器材组合产品市场的发展。老年人通常患有多种慢性疾病，例如糖尿病、高血压和关节炎。将药物输送与监测和其他支援功能结合起来的药物-器械组合产品的需求不断增长，因为它们在满足这些复杂的健康要求方面特别有利。因此，老年人口的增加正在扩大市场。

根据联合国发布的报告，全球65岁及以上人口数量预计将增加一倍以上，从2021年的7.61亿增至2050年的16亿。

糖尿病盛行率的上升正在为全球组合药物和医疗器材市场注入活力。管理糖尿病需要持续的药物治疗和监测。胰岛素帮浦和连续血糖监测仪 (CGM) 等组合药物和医疗设备产品透过将药物输送和监测整合到一台设备中，简化了糖尿病管理并提高了患者的便利性，从而推动了需求。

药物输送活动投资的增加正在推动全球药物-医疗器材组合产品市场的发展。这个市场上的公司可以开发满足特定医疗需求的产品，并且透过增加投资，可以超越当前的解决方案。因此，对更先进和现代化的药物输送设备的需求日益增长。

药品/医疗器材组合产品市场报告亮点

透皮贴片细分市场因其非侵入性性质而在 2024 年占据市场占有率，这符合对微创和患者友好型给药解决方案不断增长的需求。

药物洗脱支架段预计在研究期间将出现最高增长，因为它可以透过释放预防动脉再狭窄的药物来有效治疗冠状动脉疾病。

由于迫切需要先进技术来管理冠状动脉疾病和心臟衰竭，心血管疾病领域在 2024 年占据最大的市场占有率。

由于先进的医疗基础设施、高水准的研发活动以及支持技术创新和市场进入的强有力的监管框架，北美在 2024 年占据了市场主导地位。此外，大量主要製药和医疗器材公司的存在也有助于该领域的主导地位。

亚太地区，被预测把医疗保健部门的扩大，医疗技术的投资的增加，患者数的增加做为背景，记录在调查期间中最快的成长。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球医药品·医疗设备组合产品市场洞察

  • 市场概述
  • 医药品·医疗设备组合产品市场力学
    • 促进因素和机会
      • 糖尿病盛行率的上升推动了市场的发展
      • 全球老年人口增加促使市场扩张
    • 阻碍因素与课题
      • 复杂的监管环境抑制药品/医疗器材组合产品市场的成长
  • PESTEL分析
  • 医药品·医疗设备组合产品市场趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球医药品·医疗设备组合产品市场:各类型

  • 主要调查结果
  • 简介
  • 药物释放型血管支架
  • 输液帮浦
  • 吸入器
  • 整形外科用复合产品
  • 创伤护理复合产品
  • 光线动态疗法设备
  • 经皮吸收贴片
  • 抗菌导管
  • 其他

第6章 全球医药品·医疗设备组合产品市场:各用途

  • 主要调查结果
  • 简介
  • 心血管疾病
  • 糖尿病
  • 呼吸系统的问题
  • 癌症治疗
  • 其他

第7章 全球医药品·医疗设备组合产品市场:各终端用户

  • 主要调查结果
  • 简介
  • 医院
  • 门诊病人手术中心
  • 其他

第8章 全球医药品·医疗设备组合产品市场:各地区

  • 主要调查结果
  • 简介
    • 医药品·医疗设备组合产品市场评估:各地区，2020年～2034年
  • 北美
    • 北美:各类型，2020年～2034年
    • 北美:各用途，2020年～2034年
    • 北美:各终端用户，2020年～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各类型，2020-2034
    • 欧洲:各用途，2020年～2034年
    • 欧洲:各终端用户，2020年～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各类型，2020年～2034年
    • 亚太地区:各用途，2020年～2034年
    • 亚太地区:各终端用户，2020年～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各类型，2020年～2034年
    • 中东·非洲:各用途，2020年～2034年
    • 中东·非洲:各终端用户，2020年～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各类型，2020年～2034年
    • 南美:各用途，2020年～2034年
    • 南美:各终端用户，2020年～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第9章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第10章 企业简介

  • Abbott
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Medtronic
  • Novartis AG
  • Sensely, Inc.
  • Stryker
  • Teleflex Incorporated
  • Terumo Medical Corporation
  • Viatris Inc.
  • Hovione
Product Code: PM5167

The global drug device combination products market size is expected to reach USD 343.59 billion by 2034, according to a new study by Polaris Market Research. The report "Drug Device Combination Products Market Size, Share, Trends, Industry Analysis Report, By Type (Drug Eluting Stents, Infusion Pumps, Inhalers, Orthopedic Combination Products, Wound Care Combination Products, Photodynamic Therapy Devices, Transdermal Patches, Antimicrobial Catheters, and Others), Application, End user, and Region-Market Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising geriatric population across the globe is driving the global drug device combination products market. Elderly individuals commonly have several chronic ailments like diabetes, hypertension, and arthritis. Drug-device combination products that combine medication delivery with monitoring or other supportive functions are especially advantageous for addressing these intricate health requirements, thus increasing the need. Thus, the growing geriatric population is expanding the market. For instance,

According to a report published by the United Nations, the number of people aged 65 years or older worldwide is projected to more than double, rising from 761 million in 2021 to 1.6 billion in 2050.

The global market for drug-device combination products is being fueled by the rising incidence of diabetes. Managing diabetes involves continuous medication and monitoring. Drug-device combination products, like insulin pumps or continuous glucose monitors (CGMs), streamline diabetes management by integrating drug delivery and monitoring into one device, increasing convenience for the patient and thereby boosting demand.

The rising investments in drug delivery activities are propelling the global drug device combination products market. Companies in the market are able to create products that cater to specific medical needs and deliver better performance than current solutions with increased investment. This drives the need for more advanced and up-to-date drug delivery devices.

Drug Device Combination Products Market Report Highlights

The transdermal patches segment dominated the market share in 2024 due to their non-invasive nature, which aligns with the rising demand for minimally invasive and patient-friendly drug delivery solutions.

Drug eluting stents segment is anticipated to witness the highest growth over the study period, due to their effectiveness in treating coronary artery disease by releasing medications that prevent restenosis of the artery.

Cardiovascular disorders segment accounted for the largest market share in 2024, owing to the critical need for advanced technologies for managing coronary artery disease and heart failure.

North America dominated the market in 2024 due to the advanced healthcare infrastructure, high levels of research and development activity, and strong regulatory frameworks that support innovation and market entry. Additionally, the presence of numerous leading pharmaceutical and medical device companies contributed to the segment's dominance.

Asia Pacific is projected to register the fastest growth over the study period, attributable to the expanding healthcare sector, increasing investments in medical technology, and rising patient populations.

The global players include Abbott; Becton, Dickinson and Company; Boston Scientific Corporation; Medtronic; Novartis AG; Sensely, Inc.; Stryker; Teleflex Incorporated; Terumo Medical Corporation; Viatris Inc.; and Hovione.

Polaris Market Research has segmented the drug device combination products market report based on type, application, End user, and region.

By Type Outlook (Revenue - USD Billion, 2020 - 2034)

  • Drug Eluting Stents
  • Infusion Pumps
  • Inhalers
  • Orthopedic Combination Products
  • Wound Care Combination Products
  • Photodynamic Therapy Devices
  • Transdermal Patches
  • Antimicrobial Catheters
  • Others

By Application Outlook (Revenue - USD Billion, 2020 - 2034)

  • Cardiovascular Disorder
  • Diabetes
  • Respiratory Problems
  • Cancer Treatment
  • Others

By End user Outlook (Revenue - USD Billion, 2020 - 2034)

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Regional Outlook (Revenue - USD Billion, 2020 - 2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Drug Device Combination Products Market Insights

  • 4.1. Drug Device Combination Products Market - Market Snapshot
  • 4.2. Drug Device Combination Products Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing prevalence of diabetes is driving the market.
      • 4.2.1.2. Growing geriatric population worldwide propels the market.
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Complex regulatory environment is hindering the drug device combination products market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Drug Device Combination Products Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Drug Device Combination Products Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Drug Eluting Stents
    • 5.3.1. Global Drug Device Combination Products Market, by Drug Eluting Stents, by Region, 2020-2034 (USD Billion)
  • 5.4. Infusion Pumps
    • 5.4.1. Global Drug Device Combination Products Market, by Infusion Pumps, by Region, 2020-2034 (USD Billion)
  • 5.5. Inhalers
    • 5.5.1. Global Drug Device Combination Products Market, by Inhalers, by Region, 2020-2034 (USD Billion)
  • 5.6. Orthopedic Combination Products
    • 5.6.1. Global Drug Device Combination Products Market, by Orthopedic Combination Products, by Region, 2020-2034 (USD Billion)
  • 5.7. Wound Care Combination Products
    • 5.7.1. Global Drug Device Combination Products Market, by Wound Care Combination Products, by Region, 2020-2034 (USD Billion)
  • 5.8. Photodynamic Therapy Device
    • 5.8.1. Global Drug Device Combination Products Market, by Photodynamic Therapy Device, by Region, 2020-2034 (USD Billion)
  • 5.9. Transdermal Patches
    • 5.9.1. Global Drug Device Combination Products Market, by Transdermal Patches, by Region, 2020-2034 (USD Billion)
  • 5.10. Antimicrobial Catheters
    • 5.10.1. Global Drug Device Combination Products Market, by Antimicrobial Catheters, by Region, 2020-2034 (USD Billion)
  • 5.11. Other
    • 5.11.1. Global Drug Device Combination Products Market, by Other, by Region, 2020-2034 (USD Billion)

6. Global Drug Device Combination Products Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Cardiovascular Disorder
    • 6.3.1. Global Drug Device Combination Products Market, by Cardiovascular Disorder, by Region, 2020-2034 (USD Billion)
  • 6.4. Diabetes
    • 6.4.1. Global Drug Device Combination Products Market, by Diabetes, by Region, 2020-2034 (USD Billion)
  • 6.5. Respiratory Problems
    • 6.5.1. Global Drug Device Combination Products Market, by Respiratory Problems, by Region, 2020-2034 (USD Billion)
  • 6.6. Cancer Treatment
    • 6.6.1. Global Drug Device Combination Products Market, by Cancer Treatment, by Region, 2020-2034 (USD Billion)
  • 6.7. Other
    • 6.7.1. Global Drug Device Combination Products Market, by Other, by Region, 2020-2034 (USD Billion)

7. Global Drug Device Combination Products Market, by End-user

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Drug Device Combination Products Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 7.4. Ambulatory Surgical Centers
    • 7.4.1. Global Drug Device Combination Products Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Drug Device Combination Products Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Drug Device Combination Products Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Drug Device Combination Products Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Drug Device Combination Products Market - North America
    • 8.3.1. North America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
    • 8.3.3. North America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.3.4. Drug Device Combination Products Market - U.S.
      • 8.3.4.1. U.S.: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.3.5. Drug Device Combination Products Market - Canada
      • 8.3.5.1. Canada: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • 8.4. Drug Device Combination Products Market - Europe
    • 8.4.1. Europe: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.4. Drug Device Combination Products Market - UK
      • 8.4.4.1. UK: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.5. Drug Device Combination Products Market - France
      • 8.4.5.1. France: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.6. Drug Device Combination Products Market - Germany
      • 8.4.6.1. Germany: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.7. Drug Device Combination Products Market - Italy
      • 8.4.7.1. Italy: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.8. Drug Device Combination Products Market - Spain
      • 8.4.8.1. Spain: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.9. Drug Device Combination Products Market - Netherlands
      • 8.4.9.1. Netherlands: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.10. Drug Device Combination Products Market - Russia
      • 8.4.10.1. Russia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.4.11. Drug Device Combination Products Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • 8.5. Drug Device Combination Products Market - Asia Pacific
    • 8.5.1. Asia Pacific: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.4. Drug Device Combination Products Market - China
      • 8.5.4.1. China: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.5. Drug Device Combination Products Market - India
      • 8.5.5.1. India: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.6. Drug Device Combination Products Market - Malaysia
      • 8.5.6.1. Malaysia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.7. Drug Device Combination Products Market - Japan
      • 8.5.7.1. Japan: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.8. Drug Device Combination Products Market - Indonesia
      • 8.5.8.1. Indonesia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.9. Drug Device Combination Products Market - South Korea
      • 8.5.9.1. South Korea: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.10. Drug Device Combination Products Market - Australia
      • 8.5.10.1. Australia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.5.11. Drug Device Combination Products Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • 8.6. Drug Device Combination Products Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.6.4. Drug Device Combination Products Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.6.5. Drug Device Combination Products Market - UAE
      • 8.6.5.1. UAE: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.6.6. Drug Device Combination Products Market - Israel
      • 8.6.6.1. Israel: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.6.7. Drug Device Combination Products Market - South Africa
      • 8.6.7.1. South Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.6.8. Drug Device Combination Products Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • 8.7. Drug Device Combination Products Market - Latin America
    • 8.7.1. Latin America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.7.4. Drug Device Combination Products Market - Mexico
      • 8.7.4.1. Mexico: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.7.5. Drug Device Combination Products Market - Brazil
      • 8.7.5.1. Brazil: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.7.6. Drug Device Combination Products Market - Argentina
      • 8.7.6.1. Argentina: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
    • 8.7.7. Drug Device Combination Products Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Becton, Dickinson and Company
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Boston Scientific Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Medtronic
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Novartis AG
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Sensely, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Stryker
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Teleflex Incorporated
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Terumo Medical Corporation
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Viatris Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Hovione
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables:

  • Table 1 Global Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 3 Global Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 4 North America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 5 North America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 6 North America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 7 U.S.: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 10 Canada: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 12 Canada: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 13 Europe: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Europe: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 16 UK: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 17 UK: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 18 UK: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 19 France: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 20 France: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 21 France: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 22 Germany: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Germany: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 25 Italy: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 27 Italy: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 28 Spain: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 30 Spain: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 34 Russia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Russia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 43 China: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 44 China: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 45 China: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 46 India: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 47 India: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 48 India: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 52 Japan: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 54 Japan: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 58 South Korea: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 60 South Korea: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 61 Australia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 63 Australia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 73 UAE: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 75 UAE: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 76 Israel: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 78 Israel: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 79 South Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 81 South Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 85 Latin America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 87 Latin America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 88 Mexico: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 90 Mexico: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 91 Brazil: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Brazil: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 94 Argentina: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Argentina: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Drug Device Combination Products Market, by Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Drug Device Combination Products Market, by Application, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Drug Device Combination Products Market, by End-user, 2020-2034 (USD Billion)
  • List of Figures:
  • Figure 1. Global Drug Device Combination Products Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Drug Device Combination Products Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Drug Device Combination Products Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 10. Market by End-user
  • Figure 11. Global Drug Device Combination Products Market, by End-user, 2024 & 2034 (USD Billion)